It was a recorded in a recent boat tour organized in Sitika Whalefest Science Symposium held from November 1-4 that there is a significant increase in the number of humpback whales of Alaska.
The increase is, however, slow but the rise is of course good news for whale watchers and the species itself. The baleen is seen moving in big number through the waters. They can create problems for boaters, hatcheries and herring fleet. These whales feed on krill and small fishes in saline water.
Jan Straley, the festival science Director and a University of Alaska and Professor who researched on marine mammals for about 30 years, said they are reproducing at a rate of 6 or 7% in Southeast Alaska.
"So that means for every hundred whales we get six or seven more whales the next year. And their mortality rate isn't that high, so we're getting more and more whales", she added, saying it has some problems linked to it the same time.
Whales get killed by biog ships but when it comes to small ships, it can be problem for the one inside them. Whales are big and when small boats hit them, it gives effect like hitting a wall.
In a recent announcement, Twitter has said that it is launching a new companion app – called ‘Engage’ – to enable its users to know the people who are following their campaigns and activity on the popular microblogging platform.
Announcing...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
First human trial of a potential Zika vaccine has...
Managing sleep should now become easier with the launch...
Google lacks when anyone searches for a health problem...
In a Monday announcement, Chinese device maker Huawei...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).